Results 11 to 20 of about 180,692 (332)

Cancer of the ovary, fallopian tube, and peritoneum: 2021 update

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2021
In 2014, FIGO’s Committee for Gynecologic Oncology revised the staging of ovarian cancer, incorporating ovarian, fallopian tube, and peritoneal cancer into the same system. Most of these malignancies are high‐grade serous carcinomas (HGSC).
J. Berek, M. Renz, S. Kehoe, L. Kumar, M. Friedlander   +4 more
semanticscholar   +1 more source

Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin: A Single Center Experience

Frontiers in Surgery, 2021
Background: Pseudomyxoma peritonei (PMP) originating from appendiceal mucinous neoplasm is a rare peritoneal malignancy characterized by the progressive intraperitoneal accumulation of mucus leading to death if left untreated.
Francesco Santullo, Fabio Pacelli, Carlo Abatini, Miriam Attalla El Halabieh, Giusy Fortunato, Claudio Lodoli, Francesco Giovinazzo, Stefano Rotolo, Stefano Rotolo, Andrea Di Giorgio   +9 more
doaj   +1 more source

The Road to Technical Proficiency in Cytoreductive Surgery for Peritoneal Carcinomatosis: Risk-Adjusted Cumulative Summation Analysis

Frontiers in Surgery, 2022
BackgroundCytoreductive surgery (CRS) is a technically demanding procedure, and there is considerable debate about its safe application. This study investigated the learning curve for CRS and the clinical outcomes of consecutive patients treated by a ...
Francesco Santullo, Carlo Abatini, Miriam Attalla El Halabieh, Federica Ferracci, Claudio Lodoli, Lorenzo Barberis, Francesco Giovinazzo, Andrea Di Giorgio, Fabio Pacelli, Fabio Pacelli   +9 more
doaj   +1 more source

Peritoneal regression grading score (PRGS): first evidence for independent predictive and prognostic significance

Pleura and Peritoneum, 2023
The peritoneal regression grading score (PRGS) is a four-tied pathologic score measuring tumor regression in biopsies from patients with peritoneal metastasis (PM) receiving chemotherapy.
Baake Janina, Nadiradze Giorgi, Archid Rami, Königsrainer Alfred, Bösmüller Hans, Reymond Marc, Solass Wiebke   +6 more
doaj   +1 more source

Machine learning to predict overall short-term mortality in cutaneous melanoma

Discover Oncology, 2023
Background Cutaneous malignant melanoma (CMM) ranks among the ten most frequent malignancies, clinicopathological staging being of key importance to predict prognosis.
C. Cozzolino, A. Buja, M. Rugge, A. Miatton, M. Zorzi, A. Vecchiato, P. Del Fiore, S. Tropea, A. Brazzale, G. Damiani, L. dall’Olmo, C. R. Rossi, S. Mocellin   +12 more
doaj   +1 more source

Acidic ascites inhibits ovarian cancer cell proliferation and correlates with the metabolomic, lipidomic and inflammatory phenotype of human patients

Journal of Translational Medicine, 2022
Background The poor prognosis of ovarian cancer patients is strongly related to peritoneal metastasis with the production of malignant ascites. However, it remains largely unclear how ascites in the peritoneal cavity influences tumor metabolism and ...
Qianlu Yang, Gyuntae Bae, Giorgi Nadiradze, Arianna Castagna, Georgy Berezhnoy, Laimdota Zizmare, Aditi Kulkarni, Yogesh Singh, Frank J. Weinreich, Stefan Kommoss, Marc A. Reymond, Christoph Trautwein   +11 more
doaj   +1 more source

The Role of Electrochemotherapy in the Cutaneous and Subcutaneous Metastases From Breast Cancer: Analysis of Predictive Factors to Treatment From an Italian Cohort of Patients

Frontiers in Oncology, 2021
The treatment of cutaneous and subcutaneous localizations from breast cancer (BC) is still a therapeutic challenge. Electrochemotherapy (ECT) is one of the available options, and it is characterized by the association between the administration of a ...
Francesco Russano, Paolo Del Fiore, Claudia Di Prata, Andrea Pasqual, Roberto Marconato, Luca Giovanni Campana, Romina Spina, Carlo Maria Gianesini, Alessandra Collodetto, Saveria Tropea, Luigi Dall’Olmo, Luigi Dall’Olmo, Sabrina Carraro, Alessandro Parisi, Sara Galuppo, Giovanni Scarzello, Francesca De Terlizzi, Marco Rastrelli, Marco Rastrelli, Simone Mocellin, Simone Mocellin   +20 more
doaj   +1 more source

Prognostic Factors for Surgical Failure in Malignant Bowel Obstruction and Peritoneal Carcinomatosis

Frontiers in Surgery, 2021
Introduction: Patients with peritoneal metastasis frequently develop malignant bowel obstruction (MBO). Medical palliative management is preferred but often fails. Conversely, the role of palliative surgery remains unclear and debated. This study aims to
Claudio Lodoli, Marcello Covino, Marcello Covino, Miriam Attalla El Halabieh, Miriam Attalla El Halabieh, Francesco Santullo, Andrea Di Giorgio, Andrea Di Giorgio, Carlo Abatini, Carlo Abatini, Stefano Rotolo, Elena Rodolfino, Elena Rodolfino, Francesco Giovinazzo, Anna Fagotti, Anna Fagotti, Giovanni Scambia, Giovanni Scambia, Francesco Franceschi, Francesco Franceschi, Fabio Pacelli, Fabio Pacelli   +21 more
doaj   +1 more source

Melanoma in Adolescents and Young Adults: Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective Study

Frontiers in Oncology, 2021
The “Veneto Cancer Registry” records melanoma as the most common cancer diagnosed in males and the third common cancer in females under 50 years of age in the Veneto Region (Italy).
Paolo Del Fiore, Irene Russo, Irene Russo, Beatrice Ferrazzi, Alessandro Dal Monico, Francesco Cavallin, Angela Filoni, Saveria Tropea, Francesco Russano, Claudia Di Prata, Alessandra Buja, Alessandra Collodetto, Romina Spina, Sabrina Carraro, Rocco Cappellesso, Lorenzo Nicolè, Lorenzo Nicolè, Vanna Chiarion-Sileni, Jacopo Pigozzo, Luigi Dall’Olmo, Luigi Dall’Olmo, Marco Rastrelli, Marco Rastrelli, Antonella Vecchiato, Clara Benna, Chiara Menin, Daniela Di Carlo, Gianni Bisogno, Angelo Paolo Dei Tos, Mauro Alaibac, Simone Mocellin, Simone Mocellin   +31 more
doaj   +1 more source

Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery for gastric carcinoma at high risk of peritoneal carcinomatosis: short and long-term outcomes (GOETH STUDY)—a collaborative randomized controlled trial by ACOI, FONDAZIONE AIOM, SIC, SICE, and SICO

Trials, 2022
Introduction At the time of diagnosis, 15–20% of gastric carcinomas are in stage T4 or T4b. Furthermore, 5–20% of patients undergoing potentially curative surgery suffer from synchronous or metachronous peritoneal metastases. To date, neither surgery nor
A. Di Giorgio, C. Gerardi, C. Abatini, G. Melotti, L. Bonavina, V. Torri, F. Santullo, S. Garattini, M. De Luca, Erica Rulli, Eliana Rulli, F. Pacelli, GOETH Investigators   +12 more
doaj   +1 more source